Augmedix announces Laurie McGraw as a new board member
Laurie McGraw, former Managing Director of Allscripts, joins the Augmedix Board of Directors
SAN FRANCISCO, California. – March 10, 2022 – Augmedix, Inc. (Nasdaq: AUGX), a leading provider of automated medical documentation and data services, today announced that Laurie McGraw, a former Allscripts executive, will join the Board of Directors of Augmedix, Inc.
“We are very pleased to welcome Laurie to our board. Laurie’s extensive background in healthcare and data solutions will greatly benefit Augmedix,” said Manny Krakaris, Chief Executive Office at Augmedix. “Importantly, Laurie’s proven track record of scaling Allscripts’ EHR business unit will be invaluable during her tenure as we continue to expand our unique solutions to healthcare systems and physicians alike.”
Ms. McGraw is currently senior vice president of Health Solutions, a division of the American Medical Associations (“AMA”), where she is responsible for AMA’s data solutions used for innovation and standard setting across the healthcare industry, a position she is has been in office since February 2016. From 2013 to 2015, Ms. McGraw was Chief Executive Officer of Shareable Ink, a clinical documentation and data solutions company. From 2000 to 2013, Ms. McGraw held various leadership positions at Allscripts, including President, Enterprise Solutions and Chief Client Officer. She joined Allscripts when it was a $30 million company and oversaw its growth to a $1.5 billion company. Ms. McGraw also served as a director of development and director of customer success at ChannelHealth/IDX for ten years prior to the company’s sale to Allscripts. Mrs. McGraw received a Sc. B. with honors from Brown University.
“Augmedix is a leader in tackling the overwhelming burden of clinical documentation and giving physicians back valuable time to be with their patients. I’m impressed with his AI innovation, which is flowing into the workflows of physicians to solve one of the most important problems in healthcare – patient time,” said Ms. McGraw. “I look forward to working with the board and the Management to help Augmedix capitalize on the great opportunity and continue to grow with existing and new healthcare organizations.”
Augmedix, Inc. (Nasdaq: AUGX) provides automated medical documentation and data services for large healthcare systems and physician offices, supporting physician offices, clinics, hospitals, emergency departments and telemedicine nationwide. The company’s Ambient Automation Platform transforms the natural conversation between doctors and patients into timely and comprehensive medical notes and performs a range of related data services. These services relieve physicians of administrative burdens to allow more time for patient care. Augmedix’s proprietary platform uses automatic speech recognition, natural language processing and clinical datasets to capture the conversation surrounding the visit and create a structured medical note. The medical note structured data is then used to provide additional data services. The quality is ensured by trained medical documentation specialists. To learn more about Augmedix, visit augmedix.com.
This press release contains “forward-looking statements” that involve a number of risks and uncertainties. Words like “believe”, “may”, “will”, “estimate”, “potential”, “continue”, “anticipate”, “intend”, “expect”, “could”, “would”, “project”, “ Plans”, “goals” and variations of such words and similar expressions are intended to identify forward-looking statements. Such forward-looking statements include, but are not limited to, statements regarding the potential benefits of the appointment of Ms. McGraw to the Board of Directors for Augmedix, Augmedix’s leadership in managing the burden of clinical documentation and related matters, and Augmedix’s ability to realize the significant opportunity that the Ahead of us is to unlock and realize further growth with existing and new healthcare organizations. Forward-looking statements are based on management’s expectations as of the date of this release and are subject to a number of risks, uncertainties and assumptions, many of which involve factors or circumstances beyond our control. Our actual results could differ materially from those expressed or implied by any forward-looking statements due to a number of factors, including but not limited to those factors described in “Risk Factors” and “Discussion and Analysis of Financial Condition and Management’s Results.” are Operations” of our most recent Forms 10-K and 10-Q filed with the Securities and Exchange Commission and similar disclosures in subsequent reports filed with the SEC. The forward-looking statements contained in this press release represent our views as of the date the date of this press release and we undertake no intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.